marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Larimar Therapeutics Cash Flow 2011-2024 | LRMR
Annual Cash Flow Larimar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-33.5 M | -27.6 M | -42.1 M | -42.2 M | -22.7 M | -51.5 M | -43.8 M | -52 M | - | - | - | - | - |
Depreciation & Amortization |
311 K | 318 K | 326 K | 155 K | 78 K | 261 K | 188 K | 212 K | 70 K | 16 K | 12 K | 11 K | - |
Accounts Payables |
1.28 M | 1.69 M | 1.66 M | 2.63 M | 632 K | 3.59 M | 3.02 M | 2.57 M | 7.5 M | 2.35 M | - | - | - |
Accounts Receivables |
300 K | 100 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Larimar Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -10.4 M | - | - | - | -7.55 M | - | -20.9 M | -15 M | -7.53 M | - | -34.2 M | -22 M | -11.2 M | - | -32.3 M | -21.1 M | -8.92 M | - | -14.8 M | -8.96 M | -12.5 M | - | -39.7 M | -26.6 M | -13.3 M | - | -33.9 M | -21.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 80 K | - | - | - | 78 K | - | 240 K | 163 K | 82 K | - | 238 K | 150 K | 73 K | - | 105 K | 55 K | 23 K | - | 58 K | 38 K | 51 K | - | 209 K | 102 K | 50 K | - | 138 K | 89 K | 41 K | - | 151 K | 102 K | 50 K | - | 27 K | 14 K | 5 K | - | 10 K | 6 K | 3 K | - | 8 K | 6 K | - | - | - | - | - | - | - | - | - |
Accounts Payables |
1.69 M | 2.92 M | 1.92 M | 1.28 M | 756 K | 2.34 M | 695 K | 1.69 M | 849 K | 425 K | 2.42 M | 1.66 M | 1.77 M | 1.46 M | 3.23 M | 2.63 M | 2.63 M | 2.63 M | 2.63 M | 3.54 M | 3.54 M | 3.54 M | 632 K | 3.59 M | 3.59 M | 3.59 M | 3.59 M | 3.02 M | 3.02 M | 3.02 M | 3.02 M | 2.57 M | 2.57 M | 2.57 M | 2.57 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 2.35 M | 2.35 M | 2.35 M | 2.35 M | 2.02 M | 2.02 M | 2.02 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
900 K | 800 K | 1.1 M | 300 K | 200 K | 300 K | 300 K | 100 K | 200 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency